Quantcast

Sean Tracey: Won first Paxil birth defect case (access required)

By: Justin Rebello
Published: December 11, 2009

Tags: , ,

The first case out of over 600 in the multi-district litigation against GlaxoSmithKline over allegations that the antidepressant Paxil causes an increased risk of birth defects ended in a victory for the plaintiff.

Sean Tracey, who practices at the Tracey
» Continue Reading.

Glaxo must pay $2.5M in first Paxil test case (access required)

By: Pat Murphy
Published: October 14, 2009

Tags: ,

GlaxoSmithKline Plc must pay $2.5 million over claims that its Paxil antidepressant caused birth defects, a Pennsylvania jury concluded in the first of 600 such cases to come to trial.

Exec: Glaxo linked birth defect of fetus to Paxil (access required)

By: Pat Murphy
Published: September 18, 2009

Tags: ,

Officials of GlaxoSmithKline Plc, the U.K.’s largest drugmaker, said in 2001 that a birth defect in the fetus of a woman taking its Paxil antidepressant likely was linked to the drug, according to court testimony.

Glaxo memo suggested burying Paxil studies (access required)

By: Pat Murphy
Published: September 16, 2009

Tags: ,

An executive of GlaxoSmithKline Plc, the world’s second-biggest drugmaker, talked about burying negative studies linking its antidepressant drug Paxil to birth defects, according to a company memo introduced at a trial.

Paxil e-mails must be turned over for trial (access required)

By: Pat Murphy
Published: September 15, 2009

Tags: , ,

GlaxoSmithKline Plc’s e-mails with researchers studying birth defects allegedly caused by the drugmaker’s Paxil antidepressant must be turned over to a family suing over the drug, a federal judge ruled.

GlaxoSmithKline to defend Paxil in test-case trial (access required)

By: Pat Murphy
Published: September 11, 2009

Tags: ,

GlaxoSmithKline Plc, the world’s second-biggest drugmaker, begins a trial in Philadelphia next week in what may be a test case for more than 600 lawsuits over claims its antidepressant drug Paxil causes birth defects.

Court denies preemption in Paxil suicide attempt case (access required)

By: Justin Rebello
Published: August 10, 2009

Tags: , ,

A U.S. District Court in Wisconsin has denied GlaxoSmithKline’s claim that it is immune from liability for personal injury claims involving the anti-anxiety drug Paxil.

Attorneys prepare for pending Paxil litigation (access required)

By: Justin Rebello
Published: July 27, 2009

Tags:

Over 600 cases currently pending in multi-district litigation against Glaxo Smith Kline allege that the anti-anxiety drug Paxil has caused heart defects in infants born to mothers who were prescribed the drug during pregnancy.

Sign-up for alerts

NEW FREE WHITE PAPER: E-Discovery

This FREE e-report brought to you by Lawyers USA contains the latest tips for conducting thorough and successful electronic discovery for your trial in 2012. We’ve analyzed the latest court rulings and trends in e-discovery to help you and your clients avoid sanctions and win your case.

Click here to get your free White Paper today!